Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Alzheimer Disease Treatment market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Alzheimer Disease Treatmentmarket, defines the market attractiveness level of Alzheimer Disease Treatment market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Alzheimer Disease Treatment industry, describes the types of Alzheimer Disease Treatment market, the applications of major players and the market size, and deeply analyzes the current situation of the global Alzheimer Disease Treatment market and the development prospects and opportunities of Alzheimer Disease Treatment industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Alzheimer Disease Treatment market in Chapter 13.
By Player:
Daiichi Sankyo
Eisai
Novartis
Merz Pharma
Allergan
Teva Pharmaceutical Industries
Amgen
Eli Lilly
UCB
Ono Pharmaceutical
F Hoffmann-La Roche
Johnson & Johnson
H Lundbeck
Pfizer
By Type:
Monoamine Oxidase
Pain Inhibitor (acetylcholinesterase)
Glutamate Inhibitor
By End-User:
Hospital Pharmacy
Retail Pharmacy
Online Sales
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Alzheimer Disease Treatment Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Alzheimer Disease Treatment Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Alzheimer Disease Treatment Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Alzheimer Disease Treatment Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Alzheimer Disease Treatment Market Analysis and Outlook to 2022
-
7.1 Global Alzheimer Disease Treatment Consumption (2017-2022)
-
7.2 United States Alzheimer Disease Treatment Consumption (2017-2022)
-
7.3 Europe Alzheimer Disease Treatment Consumption (2017-2022)
-
7.4 China Alzheimer Disease Treatment Consumption (2017-2022)
-
7.5 Japan Alzheimer Disease Treatment Consumption (2017-2022)
-
7.6 India Alzheimer Disease Treatment Consumption (2017-2022)
-
7.7 South Korea Alzheimer Disease Treatment Consumption (2017-2022)
8 Region and Country-wise Alzheimer Disease Treatment Market Analysis and Outlook to 2028
-
8.1 Global Alzheimer Disease Treatment Consumption Forecast (2022-2028)
-
8.2 United States Alzheimer Disease Treatment Consumption Forecast (2022-2028)
-
8.3 Europe Alzheimer Disease Treatment Consumption Forecast (2022-2028)
-
8.4 China Alzheimer Disease Treatment Consumption Forecast (2022-2028)
-
8.5 Japan Alzheimer Disease Treatment Consumption Forecast (2022-2028)
-
8.6 India Alzheimer Disease Treatment Consumption Forecast (2022-2028)
-
8.7 South Korea Alzheimer Disease Treatment Consumption Forecast (2022-2028)
9 Global Alzheimer Disease Treatment Market Outlook by Types and Applications to 2022
-
9.1 Global Alzheimer Disease Treatment Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Monoamine Oxidase Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Pain Inhibitor (acetylcholinesterase) Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Glutamate Inhibitor Consumption and Growth Rate (2017-2022)
-
9.2 Global Alzheimer Disease Treatment Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Pharmacy Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Retail Pharmacy Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Online Sales Consumption and Growth Rate (2017-2022)
10 Global Alzheimer Disease Treatment Market Outlook by Types and Applications to 2028
-
10.1 Global Alzheimer Disease Treatment Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Monoamine Oxidase Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Pain Inhibitor (acetylcholinesterase) Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Glutamate Inhibitor Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Alzheimer Disease Treatment Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Pharmacy Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Retail Pharmacy Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Online Sales Consumption Forecast and Growth Rate (2022-2028)
11 Global Alzheimer Disease Treatment Import and Export Analysis (Top 5 Countries)
-
11.1 Global Alzheimer Disease Treatment Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Alzheimer Disease Treatment Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Alzheimer Disease Treatment Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Alzheimer Disease Treatment Market Competitive Analysis
-
14.1 Daiichi Sankyo
-
14.1.1 Daiichi Sankyo Company Details
-
14.1.2 Daiichi Sankyo Alzheimer Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Daiichi Sankyo Alzheimer Disease Treatment Product and Service
-
14.2 Eisai
-
14.2.1 Eisai Company Details
-
14.2.2 Eisai Alzheimer Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Eisai Alzheimer Disease Treatment Product and Service
-
14.3 Novartis
-
14.3.1 Novartis Company Details
-
14.3.2 Novartis Alzheimer Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Novartis Alzheimer Disease Treatment Product and Service
-
14.4 Merz Pharma
-
14.4.1 Merz Pharma Company Details
-
14.4.2 Merz Pharma Alzheimer Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Merz Pharma Alzheimer Disease Treatment Product and Service
-
14.5 Allergan
-
14.5.1 Allergan Company Details
-
14.5.2 Allergan Alzheimer Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Allergan Alzheimer Disease Treatment Product and Service
-
14.6 Teva Pharmaceutical Industries
-
14.6.1 Teva Pharmaceutical Industries Company Details
-
14.6.2 Teva Pharmaceutical Industries Alzheimer Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Teva Pharmaceutical Industries Alzheimer Disease Treatment Product and Service
-
14.7 Amgen
-
14.7.1 Amgen Company Details
-
14.7.2 Amgen Alzheimer Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Amgen Alzheimer Disease Treatment Product and Service
-
14.8 Eli Lilly
-
14.8.1 Eli Lilly Company Details
-
14.8.2 Eli Lilly Alzheimer Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Eli Lilly Alzheimer Disease Treatment Product and Service
-
14.9 UCB
-
14.9.1 UCB Company Details
-
14.9.2 UCB Alzheimer Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 UCB Alzheimer Disease Treatment Product and Service
-
14.10 Ono Pharmaceutical
-
14.10.1 Ono Pharmaceutical Company Details
-
14.10.2 Ono Pharmaceutical Alzheimer Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Ono Pharmaceutical Alzheimer Disease Treatment Product and Service
-
14.11 F Hoffmann-La Roche
-
14.11.1 F Hoffmann-La Roche Company Details
-
14.11.2 F Hoffmann-La Roche Alzheimer Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 F Hoffmann-La Roche Alzheimer Disease Treatment Product and Service
-
14.12 Johnson & Johnson
-
14.12.1 Johnson & Johnson Company Details
-
14.12.2 Johnson & Johnson Alzheimer Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.12.3 Johnson & Johnson Alzheimer Disease Treatment Product and Service
-
14.13 H Lundbeck
-
14.13.1 H Lundbeck Company Details
-
14.13.2 H Lundbeck Alzheimer Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.13.3 H Lundbeck Alzheimer Disease Treatment Product and Service
-
14.14 Pfizer
-
14.14.1 Pfizer Company Details
-
14.14.2 Pfizer Alzheimer Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.14.3 Pfizer Alzheimer Disease Treatment Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Alzheimer Disease Treatment
-
Figure Alzheimer Disease Treatment Picture
-
Table Global Alzheimer Disease Treatment Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Alzheimer Disease Treatment Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Alzheimer Disease Treatment Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Alzheimer Disease Treatment Consumption by Country (2017-2022)
-
Figure United States Alzheimer Disease Treatment Consumption and Growth Rate (2017-2022)
-
Table Europe Alzheimer Disease Treatment Consumption and Growth Rate (2017-2022)
-
Figure China Alzheimer Disease Treatment Consumption and Growth Rate (2017-2022)
-
Figure Japan Alzheimer Disease Treatment Consumption and Growth Rate (2017-2022)
-
Figure India Alzheimer Disease Treatment Consumption and Growth Rate (2017-2022)
-
Figure South Korea Alzheimer Disease Treatment Consumption and Growth Rate (2017-2022)
-
Figure Global Alzheimer Disease Treatment Consumption Forecast by Country (2022-2028)
-
Figure United States Alzheimer Disease Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Alzheimer Disease Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Alzheimer Disease Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Alzheimer Disease Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Alzheimer Disease Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Alzheimer Disease Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Monoamine Oxidase Consumption and Growth Rate (2017-2022)
-
Figure Global Pain Inhibitor (acetylcholinesterase) Consumption and Growth Rate (2017-2022)
-
Figure Global Glutamate Inhibitor Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Pharmacy Consumption and Growth Rate (2017-2022)
-
Figure Global Retail Pharmacy Consumption and Growth Rate (2017-2022)
-
Figure Global Online Sales Consumption and Growth Rate (2017-2022)
-
Figure Global Monoamine Oxidase Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Pain Inhibitor (acetylcholinesterase) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Glutamate Inhibitor Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Pharmacy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Retail Pharmacy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Online Sales Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Alzheimer Disease Treatment Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Alzheimer Disease Treatment Export by Region (Top 5 Countries) (2017-2028)
-
Table Daiichi Sankyo (Foundation Year, Company Profile and etc.)
-
Table Daiichi Sankyo Alzheimer Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Daiichi Sankyo Alzheimer Disease Treatment Product and Service
-
Table Eisai (Foundation Year, Company Profile and etc.)
-
Table Eisai Alzheimer Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eisai Alzheimer Disease Treatment Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Alzheimer Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Alzheimer Disease Treatment Product and Service
-
Table Merz Pharma (Foundation Year, Company Profile and etc.)
-
Table Merz Pharma Alzheimer Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merz Pharma Alzheimer Disease Treatment Product and Service
-
Table Allergan (Foundation Year, Company Profile and etc.)
-
Table Allergan Alzheimer Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Allergan Alzheimer Disease Treatment Product and Service
-
Table Teva Pharmaceutical Industries (Foundation Year, Company Profile and etc.)
-
Table Teva Pharmaceutical Industries Alzheimer Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Teva Pharmaceutical Industries Alzheimer Disease Treatment Product and Service
-
Table Amgen (Foundation Year, Company Profile and etc.)
-
Table Amgen Alzheimer Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amgen Alzheimer Disease Treatment Product and Service
-
Table Eli Lilly (Foundation Year, Company Profile and etc.)
-
Table Eli Lilly Alzheimer Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly Alzheimer Disease Treatment Product and Service
-
Table UCB (Foundation Year, Company Profile and etc.)
-
Table UCB Alzheimer Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table UCB Alzheimer Disease Treatment Product and Service
-
Table Ono Pharmaceutical (Foundation Year, Company Profile and etc.)
-
Table Ono Pharmaceutical Alzheimer Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Ono Pharmaceutical Alzheimer Disease Treatment Product and Service
-
Table F Hoffmann-La Roche (Foundation Year, Company Profile and etc.)
-
Table F Hoffmann-La Roche Alzheimer Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table F Hoffmann-La Roche Alzheimer Disease Treatment Product and Service
-
Table Johnson & Johnson (Foundation Year, Company Profile and etc.)
-
Table Johnson & Johnson Alzheimer Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson & Johnson Alzheimer Disease Treatment Product and Service
-
Table H Lundbeck (Foundation Year, Company Profile and etc.)
-
Table H Lundbeck Alzheimer Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table H Lundbeck Alzheimer Disease Treatment Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Alzheimer Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Alzheimer Disease Treatment Product and Service
-
